Skip to search formSkip to main contentSkip to account menu

palbociclib 75 MG Oral Capsule

Known as: PALBOCICLIB 75MG CAP,ORAL, PALBOCICLIB 75MG CAP,ORAL [VA Product], PALBOCICLIB 75MG ORAL CAP 
National Institutes of Health

Related topics

Related topics

3 relations
Kinase Inhibitors [MoA]Oral Capsulepalbociclib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells
PD0332991 (palbociclib/Ibrance®) is a cyclin-dependent kinase (CDK)4/6 inhibitor that has recently been approved for the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)